Clinicopathologic features and treatment strategies for patients with pancreatic adenocarcinoma and ovarian metastases

Gynecologic Oncology

Volumn 108, Issue 3, 2008, Pages 515-519

  Falchook, Gerald S ^a   Wolff, Robert A ^a   Varadhachary, Gauri R ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Adenocarcinoma; Cytoreduction; Metastases; Mucinous; Ovary; Pancreas

Indexed keywords

GEMCITABINE;

ABDOMINAL HYSTERECTOMY; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; OVARIECTOMY; OVARY METASTASIS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; TREATMENT RESPONSE;

EID: 39249084599     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.11.012     Document Type: Article

References (31)

1. Ayhan A., Tuncer Z.S., and Bukulmez O. Malignant tumors metastatic to the ovaries. J Surg Oncol 60 (1995) 268-276
2. Baker P.M., and Oliva E. Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update. Int J Gynecol Pathol 24 1 (2005) 39-55
3. Demopoulos R.I., Touger L., and Dubin N. Secondary ovarian carcinoma: a clinical and pathological evaluation. Int J Gynecol Pathol 6 (1987) 166-175
4. lbright T.M., Roth L.M., and Stehman F.B. Secondary ovarian neoplasia. A clinicopathologic study of 35 cases. Cancer 53 (1984) 1164-1174
5. Shi Y., Ye D., Lu W., Zhao C., Xu J., and Chen L. Histological classification in 10 288 cases of ovarian malignant tumors in China. Zhonghua Fu Chan Ke Za Zhi 37 2 (2002) 97-100
6. Ayhan A., Guvenal T., Salman M.C., Ozyuncu O., Sakinci M., and Basaran M. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries. Gynecol Oncol 98 2 (2005) 235-241
7. Ronnett B.M., Kurman R.J., Shmookler B.M., Sugarbaker P.H., and Young RH. The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol 21 10 (1997) 1144-1155
8. Hart W.R. Diagnostic challenge of secondary (metastatic) ovarian tumors simulating primary endometrioid and mucinous neoplasms. Pathol Int 55 5 (2005) 231-243
9. Liu L.Y. Metastatic cancer in the ovary-report of 57 cases. Zhonghua Zhong Liu Za Zhi 11 6 (1989) 464-467
10. Petru E., Pickel H., Heydarfadai M., Lahousen M., Haas J., Schaider H., et al. Nongenital cancers metastatic to the ovary. Gynecol Oncol 44 1 (1992) 83-86
11. Kiyokawa T., Young R.H., and Scully R.E. Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol 30 3 (2006) 277-299
12. Prat J. Ovarian carcinomas, including secondary tumors: diagnostically challenging areas. Mod Pathol 18 Suppl 2 (2005) S99-S111
13. Young R.H., and Hart W.R. Metastases from carcinomas of the pancreas simulating primary mucinous tumors of the ovary. A report of seven cases. Am J Surg Pathol 13 9 (1989) 748-756
14. Niwa K., Yoshimi N., Sugie S., Sakamoto H., Tanaka T., Kato K., et al. A case of double cancer (pancreatic and ovarian adenocarcinomas) diagnosed by exfoliative and fine needle aspiration cytology. J Clin Oncol 18 2 (1988) 167-173
15. Fujiwara K., Ohishi Y., Koike H., Sawada S., Moriya T., and Kohno I. Clinical implications of metastases to the ovary. Gynecol Oncol 59 1 (1995) 124-128
16. Moore R.G., Chung M., Granai C.O., Gajewski W., and Steinhoff M.M. Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gynecol Oncol 93 1 (2004) 87-91
17. Yazigi R., and Sandstad J. Ovarian involvement in extragenital cancer. Gynecol Oncol 34 1 (1989) 84-87
18. McCluggage W.G., and Wilkinson N. Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. Histopathology 47 3 (2005) 231-247
19. Lee K.R., and Young R.H. The distinction between primary and metastatic mucinous carcinomas in the ovary. Gross and histologic findings in 50 cases. Am J Surg Pathol 27 (2003) 281-292
20. Seidman J.D., Horbayne-Szakaly I., Haiba M., Boice C.R., Kurman R.J., and Ronnett B.M. The histologic type and stage distribution of ovarian carcinomas of surface epithelial type. Int J Gynecol Pathol 23 (2004) 41-44
21. Loy T.S., Calaluce R.D., and Keeney G.L. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol 9 (1996) 1040-1044
22. Berezowski K., Stanstny J.F., and Kornstein M.J. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 9 (1996) 426-429
23. Vang R., Gown A.M., Barry T.S., Wheeler D.T., and Ronnett B.M. Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases. Mod Pathol 19 1 (2006) 97-105
24. Dionigi A., Facco C., Tibiletti M.G., Bernasconi B., Riva C., and Capella C. Ovarian metastases from colorectal carcinoma: clinicopathologic profile, immunophenotype, and karyotype analysis. Am J Clin Pathol 114 (2000) 111-122
25. Lagendijk J.H., Mullink H., Van Diest P.J., Meijer G.A., and Meijer C.J. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Hum Pathol 29 (1998) 491-497
26. Wauters C.C., Smedts F., Gerrits L.G., Bosman F.T., and Ramaekers F.C. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol 26 (1995) 852-855
27. Tenti P., Aguzzi A., Riva C., Usellini L., Zappatore R., Bara J., et al. Ovarian mucinous tumors frequently express markers of gastric, intestinal, and pancreatobiliary epithelial cells. Cancer 69 8 (1992) 2131-2142
28. Goldstein N.S., Bassi D., and Uzieblo A. WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms. Am J Clin Pathol 116 2 (2001) 246-252
29. Heinemann V., Quietzsch D., Gieseler F., Gonnermann M., Schonekas H., Rost A., et al. Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer. J Clin Oncol 24 24 (2006) 3946-3952
30. Abou-Alfa G.K., Letourneau R., Harker G., Modiano M., Hurwitz H., Tchekmedyian N.S., et al. Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer. J Clin Oncol 24 27 (2006) 4441-4447
31. Stathopoulos G.P., Syrigos K., Aravantinos G., Polyzos A., Papakotoulas P., Fountzilas G., et al. A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer. Br J Cancer 95 5 (2006) 587-592